Abstract:Background: Psoriasis is an inflammatory skin disease associated with multiple comorbidities and substantially diminishes patients' quality of life. The gut microbiome has become a hot topic in psoriasis as it has been shown to affect both allergy and autoimmunity diseases in recent studies. Our objective was to identify differences in the fecal microbial composition of patients with psoriasis compared with healthy individuals to unravel the microbiota profiling in this autoimmune disease. Results: We collected fecal samples from 30 psoriasis patients and 30 healthy controls, sequenced them by 16S rRNA high-throughput sequencing, and identified the gut microbial composition using bioinformatic analyses including Quantitative Insights into Microbial Ecology (QIIME) and Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt). Our results showed that different relative abundance of certain bacterial taxa between psoriasis patients and healthy individuals, including Faecalibacterium and Megamonas, were increased in patients with psoriasis. It's also implicated that many cytokines act as main effect molecules in the pathology of psoriasis. We selected the inflammation-related indicators that were abnormal in psoriasis patients and found the microbiome variations were associated with the level of them, especially interleukin-2 receptor showed a positive relationship with Phascolarctobacterium and a negative relationship with the Dialister. The relative abundance of Phascolarctobacterium and Dialister can be regard as predictors of psoriasis activity. The correlation analysis based on microbiota and Inflammation-related indicators showed that microbiota dysbiosis might induce an abnormal immune response in psoriasis. Conclusions: We concluded that the gut microbiome composition in psoriasis patients has been altered markedly and provides evidence to understand the relationship between gut microbiota and psoriasis. More mechanistic experiments are needed to determine whether the differences observed in gut microbiota are the cause or consequences of psoriasis and whether the relationship between gut microbiota and cytokines was involved.

Research progress of the relationship between skin barrier and psoriasis

Research progress of skin barrier defects in atopic dermatitis

Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis: Potential Pathogenesis

Skin and Gut Microbiome in Psoriasis: Gaining Insight Into the Pathophysiology of It and Finding Novel Therapeutic Strategies

Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties

Advances in the mechanism of action of short-chain fatty acids in psoriasis

Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition

Advances in the pathogenesis of psoriasis: from keratinocyte perspective

Gut microbiota and psoriasis: pathogenesis, targeted therapy, and future directions

Interleukin-1o and Psoriasis

Immune cells in the epithelial immune microenvironment of psoriasis: emerging therapeutic targets

"Gut-skin"axis: understanding psoriasis from the gut

Use of Neohydrin Scans and Roentgenograms in Evaluation of Renal Hypertension

Changes of Cutaneous Microcirculatory in Psoriasis

Enabling a self-organized traffic system in existing legacy hardware

Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients

Gut–Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis

Signaling pathways and targeted therapies for psoriasis

Critical role of environmental factors in the pathogenesis of psoriasis

Advancements in the maintenance of skin barrier/skin lipid composition and the involvement of metabolic enzymes

Mast cells as important regulators in the development of psoriasis